🇺🇸 Minodronate in United States

12 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Atypical Femur Fracture — 3 reports (25%)
  2. Abscess Jaw — 1 report (8.33%)
  3. Alveolar Osteitis — 1 report (8.33%)
  4. Bone Density Increased — 1 report (8.33%)
  5. Bone Pain — 1 report (8.33%)
  6. Fall — 1 report (8.33%)
  7. Femur Fracture — 1 report (8.33%)
  8. Fracture Nonunion — 1 report (8.33%)
  9. Groin Pain — 1 report (8.33%)
  10. Osteitis — 1 report (8.33%)

Source database →

Other Bone approved in United States

Frequently asked questions

Is Minodronate approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Minodronate in United States?

Peking University Third Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.